Literature DB >> 20443950

Immunoregulation in TB: observations and implications.

Jerrold J Ellner1.   

Abstract

Regulation of the immune response during active tuberculosis (TB) has been partly deciphered. In pulmonary TB there is transient systemic immunosuppression due to overexpression of transforming growth factor beta and interleukin-10. This is superimposed on a primary T-cell defect. Locally there is intense inflammation (lung, pleural fluid) with overexpression of immunosuppressive factors (bronchoalveolar lavage) and extensive apoptosis. These observations suggest that immune therapies should be aimed at neutralizing the negative regulatory factors rather than accentuating an already intense immune response. Also a partially effective vaccine carries the potential risk of exacerbating disease.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20443950      PMCID: PMC5439601          DOI: 10.1111/j.1752-8062.2010.00180.x

Source DB:  PubMed          Journal:  Clin Transl Sci        ISSN: 1752-8054            Impact factor:   4.689


  31 in total

1.  Pleural fluid and peripheral blood lymphocyte function in tuberculosis.

Authors:  J J Ellner
Journal:  Ann Intern Med       Date:  1978-12       Impact factor: 25.391

2.  In vitro restoration of T cell responses in tuberculosis and augmentation of monocyte effector function against Mycobacterium tuberculosis by natural inhibitors of transforming growth factor beta.

Authors:  C S Hirsch; J J Ellner; R Blinkhorn; Z Toossi
Journal:  Proc Natl Acad Sci U S A       Date:  1997-04-15       Impact factor: 11.205

3.  Induction of interleukin 1 and tumor necrosis factor by mycobacterial proteins: the monocyte western blot.

Authors:  R S Wallis; M Amir-Tahmasseb; J J Ellner
Journal:  Proc Natl Acad Sci U S A       Date:  1990-05       Impact factor: 11.205

Review 4.  Regulatory T cells and autoimmune disease.

Authors:  Silke Paust; Harvey Cantor
Journal:  Immunol Rev       Date:  2005-04       Impact factor: 12.988

5.  Depressed T-cell interferon-gamma responses in pulmonary tuberculosis: analysis of underlying mechanisms and modulation with therapy.

Authors:  C S Hirsch; Z Toossi; C Othieno; J L Johnson; S K Schwander; S Robertson; R S Wallis; K Edmonds; A Okwera; R Mugerwa; P Peters; J J Ellner
Journal:  J Infect Dis       Date:  1999-12       Impact factor: 5.226

6.  Randomized trial of adjunctive interleukin-2 in adults with pulmonary tuberculosis.

Authors:  John L Johnson; Emmanuel Ssekasanvu; Alphonse Okwera; Harriet Mayanja; Christina S Hirsch; Joseph G Nakibali; Dana Drzayich Jankus; Kathleen D Eisenach; W Henry Boom; Jerrold J Ellner; Roy D Mugerwa
Journal:  Am J Respir Crit Care Med       Date:  2003-04-17       Impact factor: 21.405

7.  Apoptosis and T cell hyporesponsiveness in pulmonary tuberculosis.

Authors:  C S Hirsch; Z Toossi; G Vanham; J L Johnson; P Peters; A Okwera; R Mugerwa; P Mugyenyi; J J Ellner
Journal:  J Infect Dis       Date:  1999-04       Impact factor: 5.226

8.  Sputum cytokine levels in patients with pulmonary tuberculosis as early markers of mycobacterial clearance.

Authors:  Rodrigo Ribeiro-Rodrigues; Tatiana Resende Co; John L Johnson; Fabiola Ribeiro; Moises Palaci; Ricardo T Sá; Ethel L Maciel; Fausto E Pereira Lima; Valderio Dettoni; Zahra Toossi; W Henry Boom; Reynaldo Dietze; Jerrold J Ellner; Christina S Hirsch
Journal:  Clin Diagn Lab Immunol       Date:  2002-07

9.  Enhanced responses to Mycobacterium tuberculosis antigens by human alveolar lymphocytes during active pulmonary tuberculosis.

Authors:  S K Schwander; M Torres; E Sada; C Carranza; E Ramos; M Tary-Lehmann; R S Wallis; J Sierra; E A Rich
Journal:  J Infect Dis       Date:  1998-11       Impact factor: 5.226

10.  Defective interleukin 2 production and responsiveness in human pulmonary tuberculosis.

Authors:  Z Toossi; M E Kleinhenz; J J Ellner
Journal:  J Exp Med       Date:  1986-05-01       Impact factor: 14.307

View more
  16 in total

1.  Coexistent Malnutrition Is Associated with Perturbations in Systemic and Antigen-Specific Cytokine Responses in Latent Tuberculosis Infection.

Authors:  Rajamanickam Anuradha; Saravanan Munisankar; Yukthi Bhootra; Nathalla Pavan Kumar; Chandrakumar Dolla; Paul Kumaran; Subash Babu
Journal:  Clin Vaccine Immunol       Date:  2016-04-04

2.  Reduced systemic and mycobacterial antigen-stimulated concentrations of IL-1β and IL-18 in tuberculous lymphadenitis.

Authors:  Gokul Raj Kathamuthu; Kadar Moideen; Dhanaraj Bhaskaran; Gomathi Sekar; Rathinam Sridhar; Bharathi Vidyajayanthi; Ganeshan Gajendraraj; Subash Babu
Journal:  Cytokine       Date:  2016-10-26       Impact factor: 3.861

3.  New biomarkers with relevance to leprosy diagnosis applicable in areas hyperendemic for leprosy.

Authors:  Annemieke Geluk; Kidist Bobosha; Jolien J van der Ploeg-van Schip; John S Spencer; Sayera Banu; Marcia V S B Martins; Sang-Nae Cho; Kees L M C Franken; Hee Jin Kim; Yonas Bekele; Mohammad K M Uddin; Sheikh Abdul Hadi; Abraham Aseffa; Maria C V Pessolani; Geraldo M B Pereira; Hazel M Dockrell; Tom H M Ottenhoff
Journal:  J Immunol       Date:  2012-04-13       Impact factor: 5.422

4.  Enhanced Mycobacterial Antigen-Induced Pro-Inflammatory Cytokine Production in Lymph Node Tuberculosis.

Authors:  Gokul Raj Kathamuthu; Kadar Moideen; Rathinam Sridhar; Dhanaraj Baskaran; Subash Babu
Journal:  Am J Trop Med Hyg       Date:  2019-06       Impact factor: 2.345

5.  Postexposure subunit vaccination against chronic enteric mycobacterial infection in a natural host.

Authors:  Wiebren Santema; Victor Rutten; Ruud Segers; Jacqueline Poot; Selma Hensen; Hans Heesterbeek; Ad Koets
Journal:  Infect Immun       Date:  2013-03-18       Impact factor: 3.441

6.  Modulation of pro- and anti-inflammatory cytokines in active and latent tuberculosis by coexistent Strongyloides stercoralis infection.

Authors:  Parakkal Jovvian George; Nathella Pavan Kumar; Jeeva Jaganathan; Chandrakumar Dolla; Paul Kumaran; Dina Nair; Vaithilingam V Banurekha; Kui Shen; Thomas B Nutman; Subash Babu
Journal:  Tuberculosis (Edinb)       Date:  2015-10-08       Impact factor: 3.131

7.  CD4 lymphocyte dynamics in Tanzanian pulmonary tuberculosis patients with and without HIV co-infection.

Authors:  Aase B Andersen; Nyagosya S Range; John Changalucha; George Praygod; Jeremiah Kidola; Daniel Faurholt-Jepsen; Henrik Krarup; Harleen M S Grewal; Henrik Friis
Journal:  BMC Infect Dis       Date:  2012-03-21       Impact factor: 3.090

8.  IL-10 dependent suppression of type 1, type 2 and type 17 cytokines in active pulmonary tuberculosis.

Authors:  Nathella Pavan Kumar; Venugopal Gopinath; Rathinam Sridhar; Luke E Hanna; Vaithilingam V Banurekha; Mohideen S Jawahar; Thomas B Nutman; Subash Babu
Journal:  PLoS One       Date:  2013-03-27       Impact factor: 3.240

9.  Malaria prevention reduces in-hospital mortality among severely ill tuberculosis patients: a three-step intervention in Bissau, Guinea-Bissau.

Authors:  Raffaella Colombatti; Martina Penazzato; Federica Bassani; Cesaltina Silva Vieira; Antonia Araujo Lourenço; Fina Vieira; Simone Teso; Carlo Giaquinto; Fabio Riccardi
Journal:  BMC Infect Dis       Date:  2011-03-02       Impact factor: 3.090

10.  Role of PPE18 protein in intracellular survival and pathogenicity of Mycobacterium tuberculosis in mice.

Authors:  Khalid Hussain Bhat; Asma Ahmed; Santosh Kumar; Pawan Sharma; Sangita Mukhopadhyay
Journal:  PLoS One       Date:  2012-12-28       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.